3 Promising ASX Penny Stocks With Over A$60M Market Cap

The Australian market recently saw a pullback, with the ASX200 closing down 0.64% as investors took profits after a series of record days. Despite this broader market retreat, there remains interest in niche investment areas like penny stocks, which can offer unique opportunities for growth. While the term “penny stock” may seem outdated, these smaller or newer companies can still present valuable prospects when supported by strong financial foundations.

Click here to see the full list of 1,047 stocks from our ASX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cue Energy Resources Limited is an oil and gas company involved in the exploration, development, and production of petroleum products with a market capitalization of A$64.98 million.

Operations: The company generates revenue of A$49.66 million from its activities in the production and exploration of hydrocarbons.

Market Cap: A$64.98M

Cue Energy Resources, with a market cap of A$64.98 million and revenue of A$49.66 million, operates without debt, alleviating concerns over interest payments. Its short-term assets cover liabilities comfortably but fall short for long-term obligations. The company has high-quality earnings despite negative growth in the past year compared to its five-year profitability trend. Trading significantly below estimated fair value suggests potential undervaluation in the penny stock realm. The board’s experience is notable, though management tenure data is insufficient for assessment. Recent events include an upcoming AGM and shareholder calls focused on financial reports and governance matters.

• Take a closer look at Cue Energy Resources’ potential here in our financial health report.

• Examine Cue Energy Resources’ past performance report to understand how it has performed in prior years.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Optiscan Imaging Limited develops, manufactures, and commercializes endomicroscopic digital imaging technology for medical and pre-clinical applications across Australia, Germany, China, and the United States with a market cap of A$133.65 million.